Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson’s disease. Movement Disorders 2005;20:1205-1209.

Zesiewicz, TA, KL Sullivan, JL Maldonado, and RA Hauser. 2005. “Open-Label Pilot Study of Levetiracetam (Keppra) for the Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease. Movement Disorders 2005;20:1205-1209.”. Movement Disorders.

Last updated on 11/12/2024